Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults
KEY WORDSCervical cancer Screening Transmasculine Gender identity Health disparities
We are grateful to the transmasculine individuals who participated in this study. We would also like to thank the study Task Force (Tre’Andre Valentine, Mason Dunn, Landen Motyka, Thomas Lewis, Ruben Hopwood, MDiv, PhD, Yvonne Gomez-Carrion, MD, Joshua Safer, MD, FACP, Julie Thompson, PA-C, Van Bailey, EdD, and Elizabeth Boskey, PhD) and study providers (Timothy Cavanaugh, MD, Tracey Toner, NP, Ellie Doig, NP, Ryan Tappin, NP, and Jessica Piccirilli, PA).
Compliance with ethical standards
This study was approved by the Fenway Health Institutional Review Board.
Conflict of Interest
The authors declare that they do not have any conflict of interest.
- 2.Tabaac AR, Sutter ME, Wall CS, Baker KE. Gender identity disparities in cancer screening behaviors. Am J Prev Med 2018. DOI: https://doi.org/10.1016/j.amepre.2017.11.009.
- 4.James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. Transgender Survey. Washington, DC: National Center for Transgender Equality. 2016. Available at: http://www.transequality.org/sites/default/files/docs/USTS-Full-Report-FINAL.PDF. Accessed November 1, 2017.